News
Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...
A new study links changes in frailty, a measure of decreased physiological capacity that leads to fatigue, slow walking, ...
Close to 100 per cent of people who are diagnosed with non-melanoma skin cancer survive for at least five years after their diagnosis, according to a new report. For melanoma, the more serious ...
According to the American Cancer Society, the 5-year survival rate for stage 4 melanoma is 35%. This means that an estimated 35% of people with stage 4 melanoma will be alive 5 years after diagnosis.
the more serious type of skin cancer, survival rates have improved significantly to 92pc, meaning nine out of 10 patients survive at least five years. Join the Irish Independent WhatsApp channel ...
to five-year survival rates in older women with breast cancer. These findings suggest that managing frailty during chemotherapy could improve outcomes. Published in JAMA Network Open and entitled ...
The five-year survival rate for patients diagnosed with cancer makes around 60 percent in Belarus, and 63 percent of all patients suffering from cancer in the republic are able to work. As noted by ...
Although melanoma primarily affects fair-skinned people, people with darker skin are also at risk but often go undiagnosed ...
A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results